Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Mycophenolic acid
Myfortic
Routinely available
SMC (144/04)
07/03/2012
Indication
In combination with ciclosporin and corticosteroids for the prophylaxis of acute transplant rejection in adult patients receiving allogeneic renal transplants
Therapeutic Area
Malignant disease and immunosuppression
Status Description
Routinely available in line with local or regional guidance
Formulation
180mg, 360mg film-coated gastro-resistant tablets
Comments
March 2012 - Added to the Additional List. Suitable for shared care.